Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Glaston publishes the 2021 Financial Statements Bulletin on February 14, 2022, at 13.00 p.m.

Glaston Corporation    Press release                  7.2.2022 at 11.00Glaston Corporation will publish its January−December 2021 Financial Statements Bulletin on Monday, 14 February 2022 at around 13.00 p.m. Finnish time. The Financial Statements Bulletin and presentation will be available as soon as possible after publishing on the Company’s internet pages at www.glaston.net.Glaston’s President and CEO Anders Dahlblom and CFO Päivi Lindqvist will present the financial result to analysts, investors and media representatives on the same day at 15.00 (Finnish time) in English. The live

Invitation to Fractal Gaming Group’s Year-end report, Q4 2021

Fractal Gaming Group AB will publish its Year-end report, Q4 on Thursday, February 10, 2022 at 08.00 (CET). In conjunction to this, a telephone and web conference will be organized for investors, analysts and media on the same day at 09.00 (CET). CEO, Hannes Wallin and CFO, Karin Ingemarson will present and comment on the report and the conference followed by a question and answer session.To attend the telephone or web conference:SE: +46856642706UK: +443333009032US: +16319131422  Link to web conference:https://tv.streamfabriken.com/fractal-gaming-group-q4-2021  For more

Devyser acquires Italian SmartSeq and strengthens position in genetic data analysis

Stockholm, February 7, 2022 – Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announced that the company has utilized an option to acquire all of the remaining shares in the associated company SmartSeq S.r.l. (“SmartSeq”). The acquisition corresponds to 70% of shares in SmartSeq and the purchase consideration amounts to EUR 835,000, of which 29% in cash and 71% in newly issued Devyser shares. The acquisition strengthens Devyser’s customer offering for diagnostic analysis and is expected to have a positive impact on Devyser’s gross profit and gross margin. In

UK food companies choose DUG for vegetarian and vegan products

Veg of Lund has started selling its plant-based drink DUG directly to food manufacturers in the UK. This category consists of convenience food suppliers, beverage manufacturers and developers of new dishes, that complements Veg of Lund’s existing customer categories.The launch of Veg of Lund’s DUG[®] plant-based drink in the UK has been primarily through supermarkets and cafés. In a short period of time, DUG has gained consumer appreciation and several media outlets have given the drink high ratings in tests of the range of plant-based products. As the UK business sector reboots in 2022

Shareholder Letter and Invitation to webcast Presentation

Oslo, February 7, 2022 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical" or the "Company"), a Nordic-based medtech company focused on developing and commercializing proprietary and innovative medtech products to the global market through organic growth and targeted M&A, today publishes a shareholder letter (in Norwegian) in relation to the fully underwritten rights issue in the Company (the "Rights Issue"). The Rights Issue was approved at the Company's extraordinary general meeting, hosted Friday, February 4, 2022. The letter to our shareholders is enclosed to this release. The

DBP International AB: a new patent for SA-033 is granted in Japan

Double Bond Pharmaceutical's forth patent application for organ-specific administration of hydrophilic cancer drug to the liver which forms the basis for the BeloGal® technology platform has been granted in Japan. Patent approval provides protection for the treatment method and the design of composition for DBP's front-line product SA-033. "We are very pleased because it is an important milestone in the development of balanced product pipeline", - comments Igor Lokot, CEO of DBP. More about SA-033: SA-033 is the first drug candidate that DBP has developed using its innovative drug

Sales of zinc with a low climate footprint launched

Boliden has started sales of zinc with a low climate footprint. The new product emits less than 1 tonne of carbon dioxide emissions per tonne of zinc, compared with the industry average of 2.5 tonnes. Low carbon zinc will stand for 18 percent of Boliden's total zinc production.The main area of use for zinc is galvanization of steel structures, which protects against rust and extends the service life of the structures. Boliden is Europe's largest mining producer in zinc and the third largest in smelter production. "The interest in metals with low climate impact is very high. We now

Truecaller partners with multiple world leading smartphone manufacturers; targeting 100 million device integrations over the next two years

Truecaller, the leading global platform for verifying contacts and blocking unwanted communications, has partnered with several world leading Android smartphone manufacturers to preload the Truecaller app on smartphones in key markets such as India, Indonesia, Malaysia and Latin America. Truecaller is platform agnostic and aims to work with as many smartphone makers as possible in the future.“Truecaller remains one of the most downloaded apps in several large countries. However, not every smartphone user is tech-savvy enough to download an app. Anecdotally, we often hear how first-time

Sproud first to launch plantbased vanilla drink based on Pea Protein

[SPROUD Vanilla]     Sproud is joining the global vanilla flavour trend and introducing Sproud Vanilla, a new flavor of plant-based milk made with pea protein. Perfect for smoothies or other treats, Sproud Vanilla is a healthy and climate-friendly option that is certified by Sugarwise to have a low sugar content.     There is a noticeable desire for plant-based drinks with a vanilla flavour on the international market. Sproud is now fulfilling this demand in UK by launching Sproud Vanilla, which is the first plant-based vanilla drink made from pea protein. This product can

Norse Atlantic Airways launches Cadet Program with OSM Aviation Academy

Norse Atlantic Airways and OSM Aviation Academy have agreed to work together to launch a cadet program that will prepare the flight academy’s students for a future career at the new long-haul airline.Norse will take to the skies in the second quarter of 2022 and will operate affordable flights between Europe and North America with a fleet of 15 modern and more environmentally friendly Boeing 787 Dreamliner aircraft. Once the airline is fully operational, the development and developing a cadet program will commence in close collaboration with OSM Aviation Academy. “Initiating a career

Kindred’s revenue from harmful gambling 4.0 per cent in the fourth quarter

Kindred’s commitment to contribute to a sustainable industry across all markets has continued throughout 2021. In the fourth quarter of 2021, Kindred’s share of revenue from harmful gambling increased slightly to 4.0 per cent.In February last year, Kindred Group plc (Kindred) started to communicate about its journey towards zero. The share of revenue from harmful gambling has fluctuated somewhat over the year and for the fourth quarter of 2021 it increased to 4.0 per cent from 3.3 per cent in the third quarter of 2021. The increase is based on different factors. One of them is that,

Atrium Ljungberg launches its framework for sustainability-linked financing

Atrium Ljungberg is launching a sustainability-linked bond framework. The link to sustainability underlines the company’s work to achieve its new ambitious sustainability goals and to ensure that sustainable growth will continue into the future. The results of the previous sustainability goals are presented in the framework.The framework enables investors to support Atrium Ljungberg’s goals for climate neutrality and social stability that run until 2030. This new framework ensures that sustainability-linked bonds can be issued as part of the company’s MTN programme. Atrium Ljungberg hired

Reminder: Handelsbanken’s year-end report for January –December 2021 will be presented on Wednesday, 9 February

Handelsbanken publishes its year-end report for January ­– December 2021 at 7:00 a.m. CET on Wednesday, 9 February. President and Group Chief Executive Carina Åkerström will present the Bank’s interim report at a digital press conference in Stockholm at 9:00 a.m. CET. The presentation will be held in Swedish, with simultaneous interpretation into English. A link to the presentation will be available at handelsbanken.com/ir. Members of the media wishing to take part in the question and answer session immediately following the presentation are required to register their participation.

Divio signs contract with global non-profit organization

MRR increases by USD 2’800Divio Technologies AB (publ) today announced that it has signed a new enterprise cloud management contract with a global independent non-profit organization. The contract, which includes management and optimization of cloud infrastructure and access to the Divio PaaS Toolbox, generates an initial MRR of USD 2'800.  Jon Levin, CEO of Divio Technologies AB, said: "I am very proud that this organization has chosen to work with Divio and to use the Divio platform for their web applications. We look forward to a great and rewarding collaboration. This is another

Invitation to webcast for the presentation of Lime Technologies’ Year end report, 2021

Lime Technologies’ Year end report for January-December 2021, will be published on Wednesday February 16, 2022, at 07:50 CET.The same day, at 09:30 CET; analysts, investors, media and other interested parties are invited to attend a webcast where Lime’s CEO, Nils Olsson, and CFO/Head of Investor Relations, Magnus Hansson, will comment on the published report and answer questions. The presentation will be held in English. The presentation material will be available on Lime’s website  after the webcast.

MPC Energy Solutions completes acquisition of Los Santos Solar I project in Mexico

Amsterdam/Oslo – 7 February 2022 – MPC Energy Solutions (MPCES) has completed the acquisition of Los Santos Solar I project, located in the state of Chihuahua, Mexico. The solar photovoltaic (PV) plant reinforces MPCES’ position as a regional leader in renewable energy and supports the country’s ongoing energy transition. Martin Vogt, CEO of MPC Energy Solutions, said: “Los Santos Solar I contributes towards Mexico’s goals of achieving 50% of electricity generation from clean energy by 2050 and reducing the levels of greenhouse gas emissions by 50%. We are pleased with the swift

Invitation to Presentation of Herantis Pharma’s 2H and Full Year Report 2021

Herantis Pharma Plc, Press Release, 7 February 2022 at 09:00 EET Herantis Pharma Plc (“Herantis”), developing disease modifying therapies for Parkinson’s disease, announced today that the company will report 2H and Full Year report 2021 and hold a live webinar (in English) for investors, analysts and media on: Thursday, March 3[rd], 2022, at 10:00 EET / 9:00 CET. Herantis will publish the company’s 2H and Full Year 2021 report on March 3, 2022, at 8:00 EET /7:00 CET. The management will present Herantis and comment on the 2H and Full Year 2021 Report followed by a live Q&A

SGL International A/S investigates the possibility to issue subsequent bonds under its existing bond framework

SGL International A/S (the "Company") hereby announces that it has mandated Pareto Securities AB as manager and sole bookrunner to investigate the possibility of a subsequent bond issue of EUR 75,000,000 (the "Subsequent Bond Issue") under the Company's existing bond framework of up to EUR 350,000,000 senior secured bonds with ISIN SE0015810759 (the "Bonds"), subject to inter alia market conditions. The proceeds from a potential Subsequent Bond Issue are intended to be used to finance general corporate purposes, including acquisitions, investments and repayment of any outstanding amount

Salmon Evolution initiates preparations for Indre Harøy phase 2 – signs Heads of Terms with Artec Aqua

Salmon Evolution ASA ("Salmon Evolution" or the "Company", OSE: SALME) is pleased to announce that it has entered into a Heads of Terms with Artec Aqua for the planning of the phase 2 build-out at Indre Harøy. Phase 2 is expected to in principle be identical to phase 1 and add a further 7,900 tons HOG of annual production, bringing the total planned production volume to 15,800 tons HOG per annum. Artec Aqua is the turnkey supplier for Salmon Evolution’s phase 1 project at Indre Harøy where the first smolt is expected to be released during March 2022 and with the full facility currently

year-end report 2021, January to December

strong financial positionRental income was EUR 212 million,an increase of 12.1 percent compared to the same period last year.The like-for-like vacancy rate decreased during the year by 3.4 percentage points to 13.7 percent,in line with the ambition to reduce construction related vacancy and increase the cash flow from properties. At the end of December, the market value of the property portfolio was EUR 6,020 million.The value change was EUR 1,719 million, equivalent to 14.2 percent.Akelius acquired properties for EUR 588 million during the year, mainly in the US and Canada.

Tobii is in negotiation to be the eye tracking technology provider for the Sony PlayStation VR2

Tobii AB, the global leader in eye tracking and pioneer of attention computing, announces it is currently in negotiation with Sony Interactive Entertainment (“SIE”) be the eye tracking technology provider in SIE’s new VR headset, PlayStation VR2 (PS VR2).  Tobii is not commenting on the financial impact of the deal at this time as negotiations are ongoing.  This information is information Tobii AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on

Bladder Cancer technology: New improved Blue Light Cystoscopy system receives FDA approval for use in NMIBC in the U.S.

Oslo, Norway, February 7, 2022: Photocure ASA, The Bladder Cancer Company, announces U.S. Food and Drug Administration (FDA) approval of a new and improved Blue Light system to be used with Photocure’s Cysview[®] product in Blue Light Cystoscopy (BLC[®]) procedures for the detection of NMIBC*. Manufactured and soon to be commercialized by KARL STORZ Endoscopy-America, Inc. (KARL STORZ), the new Blue Light system is approved for use in procedures requiring rigid cystoscopy. FDA approval was granted to KARL STORZ on February 4, 2022.“The successful FDA approval is great news for the bladder

There are no items matching the current filter
There are no more items matching the current filter
Back to top